Beam quality and the mystery behind the lower percentage depth dose in grid radiation therapy

Amir Hossein Karimi,Indra J. Das,Nahid Chegeni,Iraj Jabbari,Fatemeh Jafari,Ghazale Geraily

DOI: https://doi.org/10.1038/s41598-024-55197-0

IF: 4.6

2024-02-25

Scientific Reports

Abstract:Grid therapy recently has been picking momentum due to favorable outcomes in bulky tumors. This is being termed as Spatially Fractionated Radiation Therapy (SFRT) and lattice therapy. SFRT can be performed with specially designed blocks made with brass or cerrobend with repeated holes or using multi-leaf collimators where dosimetry is uncertain. The dosimetric challenge in grid therapy is the mystery behind the lower percentage depth dose (PDD) in grid fields. The knowledge about the beam quality, indexed by TPR 20/10 (Tissue Phantom Ratio), is also necessary for absolute dosimetry of grid fields. Since the grid may change the quality of the primary photons, a new should be evaluated for absolute dosimetry of grid fields. A Monte Carlo (MC) approach is provided to resolving the dosimetric issues. Using 6 MV beam from a linear accelerator, MC simulation was performed using MCNPX code. Additionally, a commercial grid therapy device was used to simulate the grid fields. Beam parameters were validated with MC model for output factor, depth of maximum dose, PDDs, dose profiles, and TPR 20/10. The electron and photon spectra were also compared between open and grid fields. The d max is the same for open and grid fields. The PDD with grid is lower (~ 10%) than the open field. The difference in TPR 20/10 of open and grid fields is observable (~ 5%). Accordingly, TPR 20/10 is still a good index for the beam quality in grid fields and consequently choose the correct in measurements. The output factors for grid fields are 0.2 lower compared to open fields. The lower depth dose with grid therapy is due to lower depth fluence with scatter radiation but it does not impact the dosimetry as the calibration parameters are insensitive to the effective beam energies. Thus, standard dosimetry in open beam based on international protocol could be used.

multidisciplinary sciences

What problem does this paper attempt to address?

The paper attempts to address the issue of lower Percentage Depth Dose (PDD) observed in grid radiation therapy. Specifically:

1. **Research Background**:
- Grid therapy has shown promising results in treating large tumors in recent years. This therapy is also known as Spatially Fractionated Radiation Therapy (SFRT) or lattice therapy.
- SFRT can be achieved using specially designed blocks made of copper or cerrobend alloy, or by using multi-leaf collimators. However, the latter has uncertainties in dose measurement.

2. **Main Issues**:
- A key issue in grid therapy is that the PDD in the grid field is significantly lower than in the open field.
- It is necessary to understand the impact of beam quality (characterized by the tissue-phantom ratio TPR20/10) on absolute dose measurement.
- Since the grid may alter the quality of primary photons, the beam quality correction factor \(k_{q,q_0}\) used for absolute dose measurement needs to be re-evaluated.

3. **Research Methods**:
- The paper employs Monte Carlo (MC) simulation methods, using the MCNPX code for simulations, and compares the results with commercial grid devices.
- A 6 MV beam was simulated, and parameters such as output factor, depth of maximum dose, PDD, and dose distribution were validated.
- The electron and photon spectra in open and grid fields were compared.

4. **Main Findings**:
- The PDD in the grid field is about 10% lower than in the open field, possibly due to reduced scattered radiation.
- Despite the lower PDD, standard protocols for dose measurement remain applicable because calibration parameters are not sensitive to effective beam energy.
- TPR20/10 remains a good indicator of beam quality and can be used to select the correct \(k_{q,q_0}\).

In summary, the paper aims to explain the lower PDD in grid fields through Monte Carlo simulation methods and to verify the impact of changes in beam quality on dose measurement.